October 2023 E-News
No images? Click here
Team Borisoff, the top fundraising team nationwide, officially starts the Walk For Alopecia™ in San Francisco.
Inaugural Walk For Alopecia™
Ends Awareness Month on a High Note!
On September 30, the finale of Alopecia Areata Awareness Month, alopecia areata community members all across the country stepped off on the inaugural Walk For Alopecia™ to drive research for more treatments and a cure, increase support for individuals and families living with alopecia, to advocate, and to end stigma. To date, our community has raised over $600,000! Together, we shined a bright light on alopecia and let the world know that it is not just hair!
Alopecia Areata Research
Depends on Clinical Trial Volunteers
Read about clinical trial volunteers, the unsung heroes of treatment development.
Pittsburgh Zoo trip with Pittsburgh Support Group members
Volunteer to Lead a NAAF Support Group
Network and Make a Difference!
Having alopecia areata can be frustrating and emotionally challenging. For this reason, NAAF has support groups led by volunteers for those living with alopecia areata and their family members. These virtual and in-person support groups are safe, comfortable, and trusting environments. But many cities and towns across the country still need NAAF support group leaders. If you are interested, click below to learn more and apply.
Men & Alopecia Areata: Our unique experiences
It's time to talk about how alopecia areata affects men. Hear from a group of men to learn about some of the challenges they have faced while living with this disease. This webinar will be moderated by NAAF Board member, Tyrone Folliard-Olson, and will be an honest discussion by panel members of experiences, struggles, and coping strategies, with time for audience questions.
This webinar is part of NAAF’s You Are Not Alone, Education and Empowerment Webinar Series,
supported by Eli Lilly and Company, Pfizer, and Sun Pharma.
Clinical Trial Announcements
To learn more about clinical trials and see the latest listings, visit www.naaf.org/studies/, and see the announcement below.
Phase 2a study of ADX-914 for the treatment of severe alopecia areata recruiting adult patients
A clinical research study is currently recruiting subjects between 18 and 75 years of age with severe alopecia areata (AA) to participate in an investigational study. The purpose is to evaluate how effective injections of the investigational drug called ADX-914 is on reducing hair loss in patients with severe AA. This study is taking place in multiple locations throughout the United States. Learn more about this study here.
Donate Today and Change a Life Forever
Thank You to Our Industry Partners
